Document Detail

Estimating the fraction reabsorbed in drugs undergoing enterohepatic circulation.
MedLine Citation:
PMID:  7153875     Owner:  NLM     Status:  MEDLINE    
A simple method of estimating the extent of biliary recycling using blood level and cumulative biliary excretion data from control and bile duct-cannulated animals is described. The method was tested in rats following an intravenous dose of [14C] temazepam. It was shown that 62% of the drug excreted in the bile of control rats was reabsorbed during each enterohepatic cycle, contributing to the secondary peak blood concentrations and a prolonged elimination half-life.
F L Tse; F Ballard; J Skinn
Related Documents :
2628845 - Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic chole...
2719075 - Hepatic immunohistochemical localization of the tight junction protein zo-1 in rat mode...
1459515 - Mitochondrial dysfunction in the non-obstructed lobe of rat liver after selective bilia...
8519525 - Renal filtration and excretion of aluminium in the rat: dose-response relationships and...
6495335 - Two-year inhalation toxicity study of propylene in f344/n rats and b6c3f1 mice.
9886835 - Macrophage colony stimulating-factor transcripts are differentially regulated in rat bo...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of pharmacokinetics and biopharmaceutics     Volume:  10     ISSN:  0090-466X     ISO Abbreviation:  J Pharmacokinet Biopharm     Publication Date:  1982 Aug 
Date Detail:
Created Date:  1983-03-24     Completed Date:  1983-03-24     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0357115     Medline TA:  J Pharmacokinet Biopharm     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  455-61     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bile / metabolism
Enterohepatic Circulation*
Pharmaceutical Preparations / metabolism*
Rats, Inbred Strains
Temazepam / metabolism
Reg. No./Substance:
0/Pharmaceutical Preparations; 846-50-4/Temazepam

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacokinetic characterization of extracorporeal therapy.
Next Document:  Effects of surfactants on the aqueous stability and solubility of beta-lactam antibiotics.